Atlas Trials

Evaluation of Inflammation and Pain Post Injection of Ranibizumab vs Aflibercept in Patients With DME

Clinical trial NCT02363621 · COMPLETED

Trial details

NCT number
NCT02363621
Sponsor
Arshad Khanani
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetic Macular Edema
Start date
2015-01-01
Primary completion
2017-10-01
Enrollment
101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.